Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Dr Dario Trapani to represent ESMO in the EMA’s HCPWP

18 Jan 2023

Dr Dario Trapani has been appointed as ESMO’s lead representative in the Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA).

The HCPWP, which brings together healthcare professional organizations as well as the EMA's scientific committees, serves as a platform for exchange of information and discussion on issues of common interest between the EMA and healthcare professionals. It also provides recommendations to the EMA and its human scientific committees on medicine-related topics.

As an eligible healthcare professional organization, ESMO has been part of the HCPWP since its establishment in 2013. As such, ESMO collaborated in the joint work of the HCPWP, provided expertise for specific cancer types, and conveyed the views of the medical oncology community on the cancer-focused initiatives of the EMA.

Dr Trapani has been a long-standing member of ESMO and is currently the Chair of the ESMO Cancer Medicines Committee. As ESMO’s lead representative, Dr Trapani will fulfill a key role in driving the discussions in the HCPWP and providing the input of the Society to the workstreams of the Working Party, whilst bringing his knowledge and experience in the cancer medicines domain.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.